Nutanix Inc vs Novavax Inc — how do they compare? Nutanix Inc trades at $53.61 (market cap $14.90B), while Novavax Inc trades at $8.06 (market cap $1.30B). The key difference: Nutanix Inc is far larger — about 11.5× Novavax Inc's market cap. Which is the better fit depends on your goals.
| NTNX | NVAX | |
|---|---|---|
Market Cap | $14.90B | $1.30B |
Sector | Technology | Health |
52-Week High | $81.12 | $11.19 |
52-Week Low | $34.41 | $6.22 |
Enterprise Value | $14.41B | $800.50M |
Trailing returns across standard periods
Nutanix, Inc. is a global leader in cloud software and hyperconverged infrastructure (HCI) solutions. The company's platform converges computing, virtualization, and storage into a single, seamless software-defined solution, enabling private, hybrid, and multi-cloud environments. Nutanix helps organizations simplify data center operations, manage their applications across various cloud platforms, and reduce IT complexity, positioning it as a key enabler of modern hybrid cloud strategies.
Read more on NTNX →Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →